Trial Profile

Open-label, Non-randomised, Single-centre, Multiple-dose, Phase 1, Pharmacokinetic Trial With a Topical Formulation of Tacrolimus in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tacrolimus (Primary)
Indications Allergic conjunctivitis; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Intestinal transplant rejection; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
Focus Pharmacokinetics
Sponsors LEO Pharma

Most Recent Events

15 Apr 2019 Status changed from recruiting to completed.
20 Feb 2019 Planned End Date changed from 1 Nov 2018 to 1 Feb 2019.
20 Feb 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Feb 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com